21 Apr 2016 16:35
Standard Form TR-1
Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the Central Bank of Ireland)i | ||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Amryt Pharma PLC | ||||
2. Reason for the notification (please tick the appropriate box or boxes): [X] An acquisition or disposal of voting rights [ ] An acquisition or disposal of financial instruments [ ] An event changing the breakdown of voting rights [ ] Other (please specify)iii: | ||||
3. Details of person subject to the notification obligationiv : | ||||
Name: AXA Investment Managers S.A. | City and country of registered office (if applicable): Paris, France
| |||
4. Full name of shareholder(s) (if different from 3.)v:
| ||||
5. Date on which the threshold was crossed or reachedvi: 19 April 2016
| ||||
6. Date on which issuer notified: 21 April 2016
| ||||
7. Threshold(s) that is/are crossed or reached: 3%, 4%, 5%, 6%, 7%, 8%, 9%
| ||||
8. Total positions of person(s) subject to the notification obligation: | ||||
% of voting rights attached to shares (total of 9.A) | % of voting rights through financial instruments(total of 9.B.1 + 9.B.2) | Total of both in % (9.A + 9.B) | Total number of voting rights of issuervii | |
Resulting situation on the date on which threshold was crossed or reached | 9.90% | 0 | 9.90% | 20,625,000 |
Position of previous notification (if applicable) | NA | NA | NA | NA |
9. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii: | |||||||||
A: Voting rights attached to shares | |||||||||
Class/type ofshares ISIN code (if possible) | Number of voting rightsix | % of voting rights | |||||||
Direct
|
Indirect
|
Direct
|
Indirect
| ||||||
GB00BDD1LS57 | 0 | 20,625,000 | 0 | 9.90% | |||||
SUBTOTAL A |
20,625,000 |
9.90% | |||||||
B 1: Financial Instruments according to Regulation 17(1)(a) of the Regulations | |||||||||
Type of financial instrument | Expirationdatex | Exercise/Conversion Periodxi | Number of voting rights that may be acquired if the instrument is exercised/converted. | % of voting rights | |||||
SUBTOTAL B.1 | |||||||||
B 2: Financial Instruments with similar economic effect according to Regulation 17(1)(b) of the Regulations | |||||||||
Type of financial instrument | Expirationdatex | Exercise/Conversion Period xi | Physical or cash settlementxii | Number of voting rights | % of voting rights | ||||
SUBTOTAL B.2 | |||||||||
10. Information in relation to the person subject to the notification obligation (please tick the applicable box):
[ ] Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.xiii
[ ] Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv:
| |||
Namexv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
AXA Investment Managers S.A. | 9.90% | 0 | 9.90% |
11. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of [date]
| |||
12. Additional informationxvi: This notification is made following the placing of Amryt Pharma Plc's ordinary shares respectively on the AIM and ESM Markets dated 19th April 2016. | |||
Done at Paris, on 21st April 2016